Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Leber Congenital Amaurosis 5-Like (LCA5L) (Middle Region) Peptide

LCA5L Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN974182
  • Antigène Tous les produits LCA5L
    LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
    Protein Region
    Middle Region
    Origine
    Humain
    Source
    • 3
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-C21orf13 antibody (Catalog #: ARP45911_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
    Synonymes
    C21orf13 Peptide, 4921526F01Rik Peptide, Lcca5l Peptide, Leber congenital amaurosis 5-like Peptide, LCA5L, lebercilin like Peptide, LCA5L Peptide, Lca5l Peptide
    Sujet
    The function of the C21orf13 protein remains unknown.

    Alias Symbols: MGC33295, C21orf13

    Protein Size: 670
    Poids moléculaire
    76 kDa
    ID gène
    150082
    NCBI Accession
    NM_152505, NP_689718
    UniProt
    O95447
Vous êtes ici:
Support technique